Head-to-head comparisons of medication uses, side effects, warnings, and more.
Spiriva Handihaler (tiotropium) and Symbicort (budesonide / formoterol) are inhalers that treat chronic obstructive pulmonary disease (COPD). Symbicort also treats asthma, and so does Spiriva Respimat. Spiriva is an anticholinergic medication that relaxes airway muscles, making it easier to breathe and control COPD and asthma. It’s dosed once a day. Symbicort combines a corticosteroid and a long-acting beta-agonist. It’s used twice daily to reduce inflammation and open your airways. Spiriva side effects include respiratory tract infections and dry mouth. Symbicort side effects also include respiratory tract infections, headaches, and throat pain.
Spiriva (tiotropium) is a medication used to help control chronic obstructive pulmonary disease (COPD) and asthma. There are two different Spiriva inhalers: Spiriva Respimat is a metered-dose inhaler, and Spiriva HandiHaler is a device that you place a capsule of medication into before you take the medication. The typical dosage for Spiriva (tiotropium) is two inhalations once a day, but the dose depends on the reason you're using it. Side effects include dry mouth, cough, and upper respiratory tract infections. Only Spiriva HandiHaler is also available as a generic version.
Symbicort (budesonide / formoterol) is a combination inhaler containing a steroid (budesonide) and a long-acting beta-agonist (formoterol). Both medications work together to treat asthma and chronic obstructive pulmonary disease (COPD). The typical dose for Symbicort (budesonide / formoterol) is 2 inhalations by mouth twice a day, about 12 hours apart. Common side effects include symptoms of common cold, such as stuffy nose and cough. It's available in two different strengths, both with generic versions.
Spiriva HandiHaler and generic
Spiriva Respimat
Asthma
COPD
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.